Title
Jerusalem and the Holy Land Rediscovered: The Prints of David Roberts (17961864),Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
Jerusalem and the Holy Land Rediscovered is comprised of 123 tinted and watercolored lithographs produced by the British artist, David Roberts, one of the first artists to travel extensively throughout the Holy Land in 1839.Traveling from Egypt across the Suez to Mount Sinai, Petra, and Jerusalem, Roberts produced a large corpus of drawings and watercolors of all the major holy sites. These works formed the basis of the tinted lithographs published soon after his return to England, a collection which enjoyed immense popularity in England and the United States and provided the public the first glimpse of the biblical landscape and monuments known only by name.This book reproduces for the first time in full color all 123 of Robertss lithographs along with the unabridged text by the Reverend George Croly, L.L.D. that accompanied the prints when they first appeared in 1842. Reproduced from one of the best preserved sets in the world, this rare edition has been in a private collection in Maryland since the 1850s and was recently acquired by the Duke University Museum of Art.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.